基于共识的营养路径改善先天性心脏病婴儿生长
该单中心前瞻性试点研究纳入先天性心脏病婴儿,在心脏手术前至4月龄、术后至12月龄实施基于共识的营养路径(营养师每周联系生长失败高风险婴儿、评估体重增长并提供喂养支持),与历史对照组比较。干预组44例、对照组38例。干预组出生至4月龄和12月龄的体重年龄Z评分变化均优于对照组,12月龄身长年龄Z评分也优于对照组;PICU停留时间干预组8.2±11.6天 vs 对照组18.3±24.0天(p=0.006)。作者认为PICU停留时间缩短可能源于营养状况改善,但需进一步研究。
要点
- 干预组出生至4月龄体重年龄Z评分变化中位数-0.9(-1.5, 0.7) vs 对照组-1.5(-2.0, -0.4),p=0.04。
- 干预组出生至12月龄体重年龄Z评分变化中位数-0.09(-1.3, 1.1) vs 对照组-0.4(1.9, 0.2),p=0.03。
- 12月龄身长年龄Z评分干预组-0.7(-1.9, -0.07) vs 对照组-1.6(-2.6, -0.4),p=0.04;4月龄时两组无显著差异(p=0.6)。
- PICU停留时间干预组8.2±11.6天 vs 对照组18.3±24.0天,p=0.006。
- 营养路径核心为营养师每周联系生长失败高风险婴儿、评估体重增长并提供喂养支持。
适用人群与场景
- 先天性心脏病婴儿,术前随访至4月龄,术后随访至12月龄。
处置流程与药物剂量
- 营养路径包括营养师每周联系生长失败风险最高的婴儿父母,评估体重增长并提供喂养支持。
研究设计与关键结果
- 单中心前瞻性试点研究,干预组44例 vs 历史对照组38例,比较术前共识营养路径对生长和临床结局的影响。
- 出生至4月龄体重年龄Z评分变化中位数:干预组-0.9(-1.5, 0.7) vs 对照组-1.5(-2.0, -0.4),p=0.04。
- 出生至12月龄体重年龄Z评分变化中位数:干预组-0.09(-1.3, 1.1) vs 对照组-0.4(1.9, 0.2),p=0.03。
- 4月龄身长年龄Z评分:干预组-0.7(-1.4, -0.1) vs 对照组-1.0(-1.9, -0.3),p=0.6。
- 12月龄身长年龄Z评分:干预组-0.7(-1.9, -0.07) vs 对照组-1.6(-2.6, -0.4),p=0.04。
- PICU停留时间:干预组8.2±11.6天 vs 对照组18.3±24.0天,p=0.006。
证据类型、等级与局限
- 证据类型:单中心前瞻性试点研究,与历史对照组比较。
- 局限:PICU停留时间缩短可能源于营养状况改善,但作者指出这需要进一步研究。
对床旁实践的改变
- 作者认为术前共识营养路径可改善先心病婴儿体重维持和生长,并可能通过改善营养状况缩短PICU停留时间,但需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Infants with congenital heart disease (CHD) often experience growth failure prior to surgery, which is associated with increased paediatric-intensive-care unit length of stay (PICU-LOS) and post-operative complications. This study assessed the impact of a pre-operative, consensus-based nutritional pathway (including support from a multi-disciplinary team) on growth and clinical outcome.
DESIGN: Single-centre prospective pilot study.
SETTING: Tertiary paediatric cardiology surgical centre.
PATIENTS: Infants with CHD.
INTERVENTION: Infants with CHD were followed for up to 4-months-of-age before cardiac surgery and then to 12-months-of-age following the implementation of the consensus-based nutritional-pathway (Intervention group: November 2017-August 2018), with outcomes compared to a historic control group. The nutrition pathway involved a dietitian contacting parents of infants with the highest risk of growth failure weekly; reviewing weight gain and providing feeding support.
MAIN OUTCOME MEASURE: Growth (weight-for-age, WAZ, and height-for-age-z-score, HAZ) at 4 and 12 months-of-age.
RESULTS: 44 infants in the intervention group were compared to 38 in the control group. Median (inter quartile range) change in WAZ from birth to 4 months-of-age (-0.9 (-1.5, 0.7)) and from birth to 12 months-of-age (-0.09 (-1.3, 1.1)) in the intervention group compared to the control group (-1.5 (-2.0, -0.4) (p = 0.04)) at 4 months-of age and at 12 months-of-age (-0.4 (1.9, 0.2) (p = 0.03)). HAZ at 4 months-of-age was -0.7 (-1.4, -0.1) vs. -1.0 (-1.9, -0.3) (p = 0.6) in the intervention and control groups respectively, and at 12 months-of-age HAZ was -0.7 (-1.9, -0.07) in the intervention group vs.-1.6 (-2.6, -0.4) in the control group (p = 0.04). Duration of PICU-LOS was 8.2 ± 11.6 days intervention vs. 18.3 ± 24.0 days control (p = 0.006).
CONCLUSION: Overall weight was well maintained and growth improved in infants who followed the pre-operative nutritional-pathway. The duration of PICU-LOS was significantly lower in the intervention group, which may be due to improved nutritional status, although this requires further investigation.
参考来源
- Marino LV, Johnson MJ, Davies NJ, et al. Improving growth of infants with congenital heart disease using a consensus-based nutritional pathway. Clin Nutr. 2019. PMID: 31734051. doi:10.1016/j.clnu.2019.10.031
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。